These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2699674)

  • 1. Pathogenesis and treatment of chronic arthritis.
    Pettipher ER
    Sci Prog; 1989; 73(292 Pt 4):521-34. PubMed ID: 2699674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
    Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
    Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.
    van Kuijk AW; Reinders-Blankert P; Smeets TJ; Dijkmans BA; Tak PP
    Ann Rheum Dis; 2006 Dec; 65(12):1551-7. PubMed ID: 16728461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Joint destruction and its repair in rheumatoid arthritis].
    Kohsaka H
    Clin Calcium; 2009 Mar; 19(3):317-23. PubMed ID: 19252241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid arthritis, cytokines and hypoxia. What is the link?
    Al-Shukaili AK; Al-Jabri AA
    Saudi Med J; 2006 Nov; 27(11):1642-9. PubMed ID: 17106534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukapheresis and pathogenetic mechanisms in rheumatoid arthritis.
    Wilder RL; Malone DG; Yarboro CH; Berkebile C; Haraoui B; Allen JB; Wahl SM
    J Clin Apher; 1984; 2(1):112-8. PubMed ID: 6336086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pathogenesis of joint destruction in chronic polyarthritis].
    Mohr W
    Radiologe; 1996 Aug; 36(8):593-9. PubMed ID: 8975275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheumatoid arthritis and cytokines].
    Kaneko S; Kondo Y; Yokosawa M; Sumida T
    Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells in rheumatic disease.
    Suurmond J; van der Velden D; Kuiper J; Bot I; Toes RE
    Eur J Pharmacol; 2016 May; 778():116-24. PubMed ID: 25943290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo.
    Bomalaski JS; Fallon M; Turner RA; Crooke ST; Meunier PC; Clark MA
    J Lab Clin Med; 1990 Dec; 116(6):814-25. PubMed ID: 2246557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagenase and prostaglandin in connective tissue destruction: cell-cell and humoral interactions.
    Dayer JM; Goldring SR; Robinson DR; Krane SM
    Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):329-43. PubMed ID: 231469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment.
    Kraan MC; Reece RJ; Smeets TJ; Veale DJ; Emery P; Tak PP
    Arthritis Rheum; 2002 Aug; 46(8):2034-8. PubMed ID: 12209505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cells and the pathogenesis of rheumatoid arthritis in humans and streptococcal cell wall arthritis in Lewis rats.
    Wilder RL; Case JP; Crofford LJ; Kumkumian GK; Lafyatis R; Remmers EF; Sano H; Sternberg EM; Yocum DE
    J Cell Biochem; 1991 Feb; 45(2):162-6. PubMed ID: 2055944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Destruction and inflammation of the joints in rheumatoid arthritis: a pathogenic hypothesis (author's transl)].
    Dayer JM; Héron JF
    Nouv Presse Med; 1981 Mar; 10(13):1065-8. PubMed ID: 6261219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatoid arthritis].
    Neumann E; Frommer K; Diller M; Müller-Ladner U
    Z Rheumatol; 2018 Nov; 77(9):769-775. PubMed ID: 29974224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.
    Meyer LH; Franssen L; Pap T
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):969-81. PubMed ID: 16980218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.